REG - BlackRock Group - SAR 6 - PERRIGO COMPANY PLC
BlackRock, Inc. disclosed a substantial acquisition of shares in Perrigo Company PLC on September 11, 2026, as per the Irish Takeover Panel's SAR 6 rules. The disclosure was made on September 14, 2026. BlackRock is the party making the disclosure, with no other persons acting in concert mentioned. The acquisition may impact Perrigo's shareholder structure and market position.
How this was made
The 30-second read
Why it matters
The filing confirms BlackRock's involvement with Perrigo, providing new information for shareholders and analysts.
Market read
First‑report of BlackRock's stake in Perrigo; may influence Perrigo's share price and sector sentiment.
What to watch
Potential concurrent undisclosed agreements or future tender offers could amplify impact.
Background
A SAR‑6 filing under the Irish Takeover Panel rules requires disclosure when a party acquires voting securities in a listed company.
Market effects
May signal increased activist or strategic interest in the consumer health sector.
UK listed health‑care stocks could see heightened scrutiny.
Limited to investors tracking large asset‑manager holdings.
Counterpoint
If the stake is minimal, the filing may be a routine compliance move with no price effect.
Key entities
- AcquirerBlackRock, Inc.
Asset manager filing the SAR‑6 disclosure.
- TargetPerrigo Company PLC
UK‑listed consumer health company subject of the acquisition.
